Globe Life Inc. (NYSE:GL) Receives $133.10 Consensus Price Target from Analysts

Shares of Globe Life Inc. (NYSE:GL) have received an average rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat reports. Four analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $135.50.

A number of brokerages recently commented on GL. Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $132.00 to $143.00 in a research report on Wednesday, January 8th. BMO Capital Markets started coverage on Globe Life in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price target on the stock. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 12th. Morgan Stanley raised their target price on Globe Life from $123.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 11th. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th.

Globe Life Stock Performance

NYSE GL opened at $123.58 on Wednesday. Globe Life has a 1-year low of $38.95 and a 1-year high of $129.18. The company has a 50 day moving average of $117.21 and a 200-day moving average of $109.80. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market cap of $10.37 billion, a price-to-earnings ratio of 10.34 and a beta of 0.81.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, equities analysts forecast that Globe Life will post 13.87 earnings per share for the current fiscal year.

Insider Activity at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 14,340 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the transaction, the chief executive officer now owns 16,396 shares of the company’s stock, valued at $1,783,884.80. The trade was a 46.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Jennifer Allison Haworth sold 9,000 shares of Globe Life stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $112.91, for a total value of $1,016,190.00. Following the transaction, the chief marketing officer now owns 13,485 shares of the company’s stock, valued at $1,522,591.35. This represents a 40.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 75,678 shares of company stock valued at $8,799,822. Insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

Institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc lifted its holdings in shares of Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after buying an additional 194 shares in the last quarter. Rakuten Securities Inc. bought a new position in shares of Globe Life during the fourth quarter worth approximately $28,000. Albion Financial Group UT acquired a new stake in shares of Globe Life in the fourth quarter valued at approximately $28,000. Avalon Trust Co bought a new stake in shares of Globe Life in the fourth quarter valued at approximately $41,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Globe Life by 32.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the period. 81.61% of the stock is currently owned by institutional investors.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.